Fulvestrant-d3

• Catalog No.: F862502
• M. F.: C32H47F5O3S
• M. W.: 606.770796
• Storage: -20°C Freezer

SYNONYMS

• IUPAC name: (1S,9R,10R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl](13,13,14-^2H₃)tetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadeca-2,4,6-triene-5,14-diol
• IUPAC Traditional name: (1S,9R,10R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl](13,13,14-^2H₃)tetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadeca-2,4,6-triene-5,14-diol
• Synonyms: ZD 9238-d3; Faslodex-d3; ZD 182780-d3; (7α,17β)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol-d3; Fulvestrant-d3; ICI 182780-d3; ZM 182780-d3

PROPERTIES

• Apperance: White Solid
• Melting Point: 128-130°C
• Solubility: Methanol
• Storage Condition: -20°C Freezer

DETAILS

Description (English)

A novel labelled steroidal estrogen antagonist reported to lack any partial agonist activity. Antineoplastic (hormonal).

REFERENCES

• Wakeling, A.E., et al.: Cancer Res., 51, 3867 (1991)
• Howell, A., et al.: Br. J. Cancer, 74, 300 (1991)
• Robertson, J.F., et al.: Cancer Res., 61, 6739 (1991)